Sanofi-Aventis's flu vaccines pass €1 billion in fourth quarter sales
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis posted a 10% increase in its fourth-quarter net income as sales of its influenza vaccines grew to almost €1.1 billion.